Article
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo.
Journal of virology - 27 Oct 2021
Chiem Kevin, Morales Vasquez Desarey, Silvas Jesus A, Park Jun-Gyu, Piepenbrink Michael S, Sourimant Julien, Lin Michelle J, Greninger Alexander L, Plemper Richard K, Torrelles Jordi B, Walter Mark R, de la Torre Juan C, Kobie James K, Ye Chengjin, Martinez-Sobrido Luis
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and has been responsible for the still ongoing coronavirus disease 2019 (COVID-19) pandemic. Prophylactic vaccines have been authorized by the U.S. Food and Drug Administration (FDA) for the prevention of COVID-19. Identification of SARS-CoV-2-neutralizing antibodies (NAbs) is important to assess vaccine protection efficacy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.